Completed PHASE1 INTERVENTIONAL 3-arm NCT03295747

Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain (PMO)

Sponsor: Robert Shulman, M.D.

Updated 8 times since 2017 Last updated: Apr 1, 2022 Started: Oct 15, 2017 Primary completion: Mar 28, 2019 Completion: Mar 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Abdominal Pain, this trial is completed. The trial is conducted by Robert Shulman, M.D. and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
May 2022 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — May 2022 [monthly]

Completed PHASE1
Feb 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jul 2018 — Feb 2020 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Jul 2018 [monthly]

Not Yet Recruiting PHASE1
Oct 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Robert Shulman, M.D.

Data source: Baylor College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States